emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

DCC / Medi-Globe Technologies

No EMAT : 109928
Announced Date : 08/09/2022
Type : Exit ,Acquisition of Majority Stake
Deal Value : Yes
Acquirer : DCC

Target : Medi-Globe Technologies
Country : Germany
Sector of activity :
  • Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Supplies
Business Description :
Founded in 1990, Medi-Globe Technologies develops, produces and markets a range of single- use products for minimally invasive diagnostic and therapeutic procedures in gastroenterology, urology and...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Medical Supplies » = 65
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
30/08/2022 Neurocrine Biosciences Diurnal Group Wales *** 109861
03/12/2021 Recordati Eusa Pharma (UK) England ** 109851

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report